M.R. Lichinitser: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Cassidy, J., Clarke, S., Diaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., Couture, F., Sirzen, F., Saltz, L.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 174 KB

english, 2008

2

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, Wolfgang Eiermann, Vladimir Semiglazov, Alexey Manikhas, Ana Lluch, Sergey Tjulandin, Milvia Zambetti, Federico Vazquez, Mikhail Byakhow, Mikhail Lichinitser, Miguel Angel Climent, Eva Ci

Journal:

Year:

2010

Language:

english

File:

PDF, 124 KB

english, 2010

3

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

I.J Diel, J.-J Body, M.R Lichinitser, E.D Kreuser, W Dornoff, V.A Gorbunova, M Budde, B Bergström

Journal:

European Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 313 KB

english, 2004

4

Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial

Gustavo Ismael, Roberto Hegg, Susanne Muehlbauer, Dominik Heinzmann, Bert Lum, Sung-Bae Kim, Tadeusz Pienkowski, Mikhail Lichinitser, Vladimir Semiglazov, Bohuslav Melichar, Christian Jackisch

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 245 KB

english, 2012

5

VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner

Vartanian, Amalia, Stepanova, Eugenia, Grigorieva, Irina, Solomko, Elico, Baryshnikov, Anatoly, Lichinitser, Mikhail

Journal:

Melanoma Research

Year:

2011

Language:

english

File:

PDF, 323 KB

english, 2011

6

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869 : A randomized controlled trial

Simon Van Belle, Michael R. Lichinitser, Rudolph M. Navari, August M. Garin, Marc L. A. Decramer, Alain Riviere, Myo Thant, Elmer Brestan, Binh Bui, Krista Eldridge, Marina De Smet, Nicole Michiels, R

Journal:

Year:

2002

Language:

english

File:

PDF, 109 KB

english, 2002

7

Tolerability and efficacy of the trifunctional antibody removab®(anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study

P Wimberger, A Burges, V Gorbounova, H Sommer, B Schmalfeldt, J Pfisterer, M Lichinitser, A Makhson, M Ströhlein, W Eiermann, M Biakhov, V Moiseenko, A du Bois, R Kimmig

Journal:

Cancer Cell International

Year:

2004

Language:

english

File:

PDF, 424 KB

english, 2004

8

Selective therapy of leukemia L1210 by a combination of deoxycytidine and lethal doses of cytosine arabinoside

V. M. Bukhman, M. R. Lichinitser, G. Ya. Svet-Moldavskii, D. M. Mkheidze

Journal:

Bulletin of Experimental Biology and Medicine

Year:

1978

Language:

english

File:

PDF, 258 KB

english, 1978

9

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during Herceptin therapy

E. G. Slavina, A. I. Chertkova, T. N. Zabotina, I. P. Gan’shina, M. R. Lichinitser

Journal:

Bulletin of Experimental Biology and Medicine

Year:

2006

Language:

english

File:

PDF, 254 KB

english, 2006

10

Clinical study of combined use of tomudex (raltitrexed) and xeloda (capecitabine) as first-line treatment for patients with metastasizing colorectal cancer

J. V. Vakhabova, N. N. Semenov, N. V. Dobrova, M. R. Lichinitser

Journal:

Bulletin of Experimental Biology and Medicine

Year:

2008

Language:

english

File:

PDF, 232 KB

english, 2008

11

Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant

J.F.R. Robertson, A. Howell, V.A. Gorbunova, T. Watanabe, T. Pienkowski, M.R. Lichinitser

Journal:

Breast Cancer Research and Treatment

Year:

2005

Language:

english

File:

PDF, 188 KB

english, 2005

12

Involvement of Apoptosis in the Formation of Vasculogenic Mimicry in the Malignant Neoplasms

A. A. Vartanyan, E. V. Stepanova, A. Yu. Baryshnikov, M. R. Lichinitser

Journal:

Doklady Biological Sciences

Year:

2005

Language:

english

File:

PDF, 146 KB

english, 2005

13

Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy

Yuriy V. Shebzukhov, Ekaterina P. Koroleva, Svetlana V. Khlgatian, Maria A. Lagarkova, Andrey A. Meshcheryakov, Mikhail R. Lichinitser, Julia Karbach, Elke Jager, Dmitry V. Kuprash, Sergei A. Nedospas

Journal:

Immunology Letters

Year:

2005

Language:

english

File:

PDF, 231 KB

english, 2005

14

Melanoma Vasculogenic Mimicry Capillary-Like Structure Formation Depends on Integrin and Calcium Signaling

AMALIA VARTANIAN, EUGENIA STEPANOVA, IRINA GRIGORIEVA, ELICO SOLOMKO, VLADIMIR BELKIN, ANATOLY BARYSHNIKOV, MIKHAIL LICHINITSER

Journal:

Microcirculation

Year:

2011

Language:

english

File:

PDF, 414 KB

english, 2011

15

Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer

A. Buzdar, D. Hayes, A. El-Khoudary, S. Yan, P. Lønning, M. Lichinitser, R. Gopal, G. Falkson, K. Pritchard, A. Lipton, K. Wolter, A. Lee, K. Fly, R. Chew, M. Alderdice, K. Burke, P. Eisenberg

Journal:

Breast Cancer Research and Treatment

Year:

2002

Language:

english

File:

PDF, 130 KB

english, 2002

16

Serological Analysis of the Repertoire of Human Cancer Antigens and Autoantigens

E. P. Koroleva, M. A. Lagarkova, S. V. Khlgatian, Yu. V. Shebzukhov, A. A. Mescheryakov, M. R. Lichinitser, S. A. Nedospasov, D. V. Kuprash

Journal:

Molecular Biology

Year:

2004

Language:

english

File:

PDF, 39 KB

english, 2004

17

2′-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside

V. M. Buchman, N. I. Belyanchikova, D. M. Mkheidze, T. A. Litovchenko, M. R. Lichinitser, M. F. Barkhotkina, G. J. Svet-Moldavsky

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1979

Language:

english

File:

PDF, 538 KB

english, 1979

18

Antagonism of 6-azauridine and 5-fluorouracil

M. N. Preobrazhenskaya, A. M. Garin, T. G. Lobova, M. P. Lichinitser, F. F. Mamedov

Journal:

Pharmaceutical Chemistry Journal

Year:

1981

Language:

english

File:

PDF, 146 KB

english, 1981

19

Application of new methodology to allow comparison of duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial

Sally Garnett, Miguel Martin, Guy Jerusalem, Lubos Petruzelka, Roberto Torres, Igor N. Bondarenko, Rustem Khasanov, Didier Verhoeven, José L. Pedrini, Iya Smirnova, Mikhail R. Lichinitser, Kelly Pende

Journal:

Year:

2011

Language:

english

File:

PDF, 44 KB

english, 2011

20

P26 HER-2 overexpressed breast cancer and brain metastases

M. Lichinitse, I. Ganshina, L. Zhukova, H. Lud, O. Meluzova

Journal:

Year:

2007

Language:

english

File:

PDF, 46 KB

english, 2007

21

Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Comparative bone turnover marker and safety data

J.J. Body, M. Lichinitser, R.E. Coleman, B. Bergström

Journal:

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

22

Intravenous and oral ibandronate have better safety and tolerability profiles than zoledronic acid: Evidence from comparative phase III trials

B. Bergström, M. Lichinitser, J.J. Body

Journal:

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

23

Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer

Jean-Jacques Body, Ingo J. Diel, Richard Bell, Martin Pecherstorfer, Michail R. Lichinitser, Alexander F. Lazarev, Debu Tripathy, Bengt Bergström

Journal:

Year:

2004

Language:

english

File:

PDF, 163 KB

english, 2004

24

3032 POSTER Health-related Quality of Life in Patients With HER2-positive Advanced Gastric or Gastroesophageal Junction Cancer With High HER2 Expression Levels – Exploratory Analysis of the Phase III ToGA Study

L. Shen, Y.K. Kang, M. Lichinitser, H.C. Chung, A. Ohtsu, Y.J. Bang, E. Van Cutsem, N. Al-Sakaff, J. Hill, A. Sawaki

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

25

445 PrefHer: a Clinical Trial to Evaluate Patient Preference for Trastuzumab Administered Subcutaneously or Intravenously in Patients with HER2-positive Early Breast Cancer

X. Pivot, A. Knoop, G. Curigliano, P. Barrett-Lee, M. Lichinitser, V. Mueller, C. Camci, J. Gligorov, N. Scotto

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 60 KB

english, 2012

26

Improvement of bone pain, quality of life and survival time of breast cancer patients with metastatic bone disease treated with intravenous ibandronate

I.J. Diel, M.R. Lichinitser, J.J. Body, K. Schlosser, J. Moecks, F. Cavalli, W. Dornoff, V.A. Gorbunova, E. McCloskey, J. Weiß, J.A. Kanis

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 118 KB

english, 1999

27

Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial

Andrew Bottomley, Patrick Therasse, Martine Piccart, Fabio Efficace, Corneel Coens, Carolyn Gotay, Marzena Welnicka-Jaskiewicz, Louis Mauriac, Jaroslaw Dyczka, Tanja Cufer, Michail R Lichinitser, Jan

Journal:

The Lancet Oncology

Year:

2005

Language:

english

File:

PDF, 136 KB

english, 2005

28

42 Phase I study for treatment of ovarian cancer patients with symptomatic ascites using the trifunctional bispecific antibody removab® (anti-CD3 X anti-EpCAM)

A. Burges, P. Wimberger, V.A. Gorbounova, H. Sommer, B. Schmalfeldt, J. Pfisterer, M. Ströhlein, M.R. Lichinitser, A.N. Makhson, R. Kimmig

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

29

Intravenous and oral ibandronate have better safety and tolerability profiles than zoledronic acid: evidence from comparative phase III trials

B. Bergström, Lichinitser, S. Tjulandin, J.-J. Body

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 138 KB

english, 2006

30

Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparative bone turnover marker and safety data

J.-J. Body, Lichinitser, S. Tjulandin, B. Bergström

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 269 KB

english, 2006

31

2108 POSTER Cardiac safety of trastuzumab in combination with epirubicin/ cyclophosphamide as first-line therapy in patients with HER2-positive metastatic breast cancer

M. Untch, S. Tjulandin, W. Jonat, H. Meerpohl, M. Lichinitser, G.M. Manikhas, F. Jänicke, M. Muscholl, M. Pauschinger, M. Lehle

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 62 KB

english, 2007

32

3501 ORAL Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC): a randomised phase III trial

Y. Kang, W. Kang, D. Shin, J. Chen, J. Xiong, J. Wang, M. Lichinitser, M. Philco, T. Suarez, J. Santamaría

Journal:

European Journal of Cancer Supplements

Year:

2007

Language:

english

File:

PDF, 56 KB

english, 2007

33

Self-Rated Pain Assessment by Patients With HER2-Positive Advanced Gastric/GEJ Cancer Treated With 5-FU/Capecitabine and Cisplatin With or Without Trastuzumab: Exploratory QOL Analysis From the Phase III ToGA Study

Yoon-Koo Kang, Lin Shen, Mikhail Lichinitser, Brad L. Stanford, Manuel Philco, Yung-Jue Bang, Eric Van Cutsem, Harald A. Weber, Nedal Al-Sakaff, Anthony R. Pritchard, Akira Sawaki

Journal:

Gastroenterology

Year:

2011

Language:

english

File:

PDF, 53 KB

english, 2011

34

Randomized comparisons of weekly versus every-3-week nab-paclitaxelin patients with metastatic breast cancer

J. O'Shauqhnessv, M. Lichinitser, S. Tjulandin, N. Davidson, H. Shaw, P. Bhar, W. Gradishar

Journal:

European Journal of Cancer Supplements

Year:

2008

Language:

english

File:

PDF, 75 KB

english, 2008

35

3043 Evaluation of efficacy of new antiemetic regimen containing aprepitant + granisetron (without dexamethasone) vs standard antiemetic regimen in highly emetogenic chemotherapy

M. Abramov, I. Polushkina, M. Lichinitser

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 47 KB

english, 2009

36

Renal Safety of Intravenous Ibandronic Acid in Breast Cancer Patients with Metastatic Bone Disease

Dr Nina V. Lyubimova, Nikolay E. Kushlinsky, Michail R. Lichinitser, Karl Schlosser

Journal:

Clinical Drug Investigation

Year:

2003

Language:

english

File:

PDF, 114 KB

english, 2003

37

First-line bevacizumab-containing therapy for breast cancer: results in patients aged >=70 years treated in the ATHENA study

Biganzoli, L., Di Vincenzo, E., Jiang, Z., Lichinitser, M., Shen, Z., Delva, R., Bogdanova, N., Vivanco, G. L., Chen, Z., Cheng, Y., Just, M., Espie, M., Vinholes, J., Hamm, C., Crivellari, D., Chmiel

Journal:

Annals of Oncology

Year:

2012

Language:

english

File:

PDF, 185 KB

english, 2012

38

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study

Ajani, J.A., Buyse, M., Lichinitser, M., Gorbunova, V., Bodoky, G., Douillard, J.Y., Cascinu, S., Heinemann, V., Zaucha, R., Carrato, A., Ferry, D., Moiseyenko, V.

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 502 KB

english, 2013

39

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Gianni, Luca, Eiermann, Wolfgang, Semiglazov, Vladimir, Lluch, Ana, Tjulandin, Sergei, Zambetti, Milvia, Moliterni, Angela, Vazquez, Federico, Byakhov, Mikhail J, Lichinitser, Mikhail, Climent, Miguel

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 294 KB

english, 2014

40

The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

Therasse, P., Mauriac, L., Welnicka, M., Bruning, P., Cufer, T., Lichinitser, R., Pluzanska, A., Tomiak, E., Koopmanschap, M., Piccart, M.

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 132 KB

english, 1999

41

DEOXYCYTIDINE AND LETHAL DOSES OF CYTARABINE IN ADVANCED MURINE LEUKÆMIA

Buchman, VladimirM, Svet-Moldavsky, GeorgeJ, Lichinitser, MishaR, Mkheidze, DemuriM

Journal:

Year:

1977

Language:

english

File:

PDF, 119 KB

english, 1977

42

CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

Pestalozzi, Bernhard C, Holmes, Eileen, de Azambuja, Evandro, Metzger-Filho, Otto, Hogge, Laurence, Scullion, Matt, Láng, István, Wardley, Andrew, Lichinitser, Mikhail, Sanchez, Roberto I Lopez, Mülle

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 198 KB

english, 2013

43

Combined chemotherapy in disseminated skin melanoma

Lichinitser, M., Abramov, M., Demidov, L., Gorbacheva, L.

Journal:

European Journal of Cancer

Year:

1999

Language:

english

File:

PDF, 145 KB

english, 1999

44

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Kang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., Philco-Salas, M., Suarez, T., Santamaria, J., Forster, G., McCloud, P. I.

Journal:

Annals of Oncology

Year:

2009

Language:

english

File:

PDF, 331 KB

english, 2009

45

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer

Gianni, L., Romieu, G. H., Lichinitser, M., Serrano, S. V., Mansutti, M., Pivot, X., Mariani, P., Andre, F., Chan, A., Lipatov, O., Chan, S., Wardley, A., Greil, R., Moore, N., Prot, S., Pallaud, C.,

Journal:

Journal of Clinical Oncology

Year:

2013

Language:

english

File:

PDF, 205 KB

english, 2013

46

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Saltz, L. B., Clarke, S., Diaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., Couture, F., Sirzen, F., Cassidy, J.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 157 KB

english, 2008

47

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Robert, Caroline, Karaszewska, Boguslawa, Schachter, Jacob, Rutkowski, Piotr, Mackiewicz, Andrzej, Stroiakovski, Daniil, Lichinitser, Michael, Dummer, Reinhard, Grange, Florent, Mortier, Laurent, Chia

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 249 KB

english, 2015

48

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S., Braun, A.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 355 KB

english, 2010

49

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM x Anti-CD3 Antibody: A Phase I/II Study

Burges, A., Wimberger, P., Kumper, C., Gorbounova, V., Sommer, H., Schmalfeldt, B., Pfisterer, J., Lichinitser, M., Makhson, A., Moiseyenko, V., Lahr, A., Schulze, E., Jager, M., Strohlein, M. A., Hei

Journal:

Clinical Cancer Research

Year:

2007

Language:

english

File:

PDF, 292 KB

english, 2007

50

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

Peeters, M, Strickland, A H, Lichinitser, M, Suresh, A V S, Manikhas, G, Shapiro, J, Rogowski, W, Huang, X, Wu, B, Warner, D, Jain, R, Tebbutt, N C

Journal:

British Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 345 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски